中国生物工程杂志

［1］ Avellaneda G E, Villeges P, Jackwood M W, et al. In vivo evaluation of the pathogenecity of isolates of infectious bronchitis virus. Avian Diseases, 1994, 38:589~597 ［2］ 孙立枢，唐宏琨，陈五岭. 两种树脂对固相法合成丙型肝炎疫苗多肽的影响. 中国生物工程杂志，2007,27(2):80～84 Sun L S, Tang H K, Cheng W L. China Biotechnology, 2007, 27 (2):80~84 ［3］ Purcell A W, McCluskey J,Rossjoh J. More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discov, 2007, 6:404~414 ［4］ Lenstra J A, Kusters J G, Koch G, et al.Antigenicity of the peplomer protein of infectious bronchitis virus. Mol Immunol, 1989, 26:7~15 ［5］ Wang L, Parr R L, King D J, et al.A highly conserved epitope on the spike protein of infectious bronchitis virus. Arch Virol, 1995,140:2201~2213 ［6］ Boots A M, Kusters J G, Van Noort J M, et al.Localization of a Tcell epitope within the nucleocapsid protein of avian coronavirus. Immunology,1991,74:8~13 ［7］ Partidos C,Stanley C,Steward M. The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptide. European Journal of Immunology ,1992, 22: 2675~2680 ［8］ Holzhutter H G, Frommel C,Kloetzel P M. A theoretical approach towards the identification of cleavagedetermining amino acid motifs of the 20 S proteasome. J Mol Biol, 1999, 286:1251~1265 ［9］ Li G J, Chen W Z, Yan W Y, et al. Comparison of immune responses against footandmouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or hgalactosidase as a carrier of immunogenic epitopes. Virology, 2004, 328, 274~281